AC
MRNA icon

Amia Capital’s Moderna MRNA Stock Holding History

Amia Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,500
Closed -$577K – 20
2021
Q3 		$577K Buy
+1,500
New +$553K 0.13% 17
2020
Q4 		– Sell
-17,607
Closed -$1.25M – 21
2020
Q3 		$1.25M Sell
17,607
-4,441
-20% -$310K 1.45% 12
2020
Q2 		$1.42M Sell
22,048
-19,945
-47% -$1.09M 1.16% 11
2020
Q1 		$1.26M Sell
41,993
-11,083
-21% -$255K 1.12% 12
2019
Q4 		$1.04M Buy
+53,076
New +$942K 0.3% 24

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amia Capital's MRNA Position: Q4 2021 in Review

Amia Capital sold out of Moderna (MRNA) in Q4 2021, closing a stake of 1,500 shares — an estimated $577K sold.

Amia Capital first reported a position in MRNA in Q4 2019 and held it in 5 quarters. The position peaked at $1.42M in Q2 2020. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Amia Capital reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Amia Capital sold 1,500 Moderna shares in Q4 2021, an estimated $577K.
  • Amia Capital first reported a position in Moderna in Q4 2019 and held it in 5 quarters.
  • Amia Capital's Moderna position peaked at $1.42M in Q2 2020.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Amia Capital's 13F filing for Q4 2021, filed 10 Feb 2022.